Anti-aging Agents


The full document isn't yet available to us from the patent office.


The present invention discloses mechanisms in the aging process and describes agents to be used for improving mitochondrial function, maintaining the cell cycle- arrested state in senescent and post mitotic cells, and thus preventing or treating age- related diseases or disorders associated with accelerated mitochondrial function loss, telomere dysfunction, and/or deterioration of the growth-arrested state. The present invention also discloses a number of compounds or compositions. The present invention further provides the use of low doses of rapamycin or its analogs as a mimic of caloric restriction in preventing age-related diseases or disorders.


Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jan 13, 2016
  • Application: Apr 12, 2010
    EP EP 15166498 A
  • Priority: Apr 12, 2010
    EP EP 10762568 A
  • Priority: Apr 12, 2010
    US US 2010/0030732 W
  • Priority: Apr 10, 2009
    US US 16833509 P
  • Priority: Apr 10, 2009
    US US 16831109 P

Download Citation

Sign in to the Lens